Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jet injection versus conventional pen for insulin aspart pharmacokinetics and pharmacodynamics
NL-OMON32491Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Maximal exogenous glucose infusion rate, Time to maximal glucose infusion rate and 2 more. Started Dec 2009; status: active, not recruiting.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON32491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32491.